AVORO CAPITAL ADVISORS LLC 13F Portfolio
AVORO CAPITAL ADVISORS LLC runs AVORO CAPITAL ADVISORS LLC and currently holds 26 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $11.14B. Their top holdings are UTHR, KRYS, MDGL, ARGX, ARWR. The top five represent 48.6% of reported portfolio weight. AVORO CAPITAL ADVISORS LLC ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, AVORO CAPITAL ADVISORS LLC initiated 1 new position. They added to 9 existing positions. They trimmed 2 positions. Their current best-performing preview position is QURE with returns of +181.71%.
Portfolio Value
$11.14B
Alpha Score
95.6
#0 of 1000
Holdings
26
AVORO CAPITAL ADVISORS LLC Current 13F Holdings
Reported holdings from AVORO CAPITAL ADVISORS LLC's latest SEC 13F filing, ranked by portfolio weight.
26 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 UTHR UNITED THERAPEUTICS CORP | 13.52% | $248.82 | $549.16 | +120.71% | Added +5.62% |
 KRYS KRYSTAL BIOTECH INC | 9.64% | $105.41 | $331.61 | +214.59% | Held |
 MDGL MADRIGAL PHARMACEUTICALS INC | 8.84% | $176.98 | $471.75 | +166.56% | Added +0.83% |
 ARGX ARGENX SE | 8.33% | $194.05 | $825.03 | +325.16% | Held |
 ARWR ARROWHEAD PHARMACEUTICALS INC | 8.31% | $30.23 | $62.75 | +107.58% | Added +6.13% |
 KYMR KYMERA THERAPEUTICS INC | 7.70% | $39.16 | $112.40 | +187.03% | Held |
 RVMD REVOLUTION MEDICINES INC | 3.86% | $80.96 | $189.76 | +134.39% | Trimmed -2.02% |
 CYTK CYTOKINETICS INC | 3.82% | $72.34 | $62.91 | -13.04% | Added +50.00% |
 CELC CELCUITY INC | 3.19% | $100.89 | $67.94 | -32.66% | Added +0.74% |
 XENE XENON PHARMACEUTICALS INC | 3.13% | $23.84 | $36.44 | +52.85% | Held |
Showing 1-10 of 26